The promise of Artificial Intelligence (AI) in life sciences is undeniable—offering advancements in drug discovery, clinical research, and evidence generation. Yet, many organizations still struggle to implement AI effectively. To better understand these challenges, CapeStart conducted a survey of 104 life science professionals, asking them: What are the top three barriers to success for your…
Organizations are recognizing the promise of Artificial Intelligence (AI). It’s becoming an essential tool for improving team performance. In CapeStart’s Life Science AI Research Report, respondents shared their internal organizational goals for exploring AI, offering a glimpse into how life science organizations are leveraging the technology to optimize efficiency and drive innovation.
Top AI Goals for…
Artificial Intelligence (AI) holds immense promise, but its successful adoption depends on two critical factors: whether teams have the capability to implement AI strategies and whether they can access the right vendor support. CapeStart’s Life Science AI Research Report sheds light on these questions, offering a deeper understanding of how organizations are navigating these challenges.
Team…
Artificial intelligence (AI) has significantly impacted the pharmaceutical business in several ways, from drug discovery and formulation to clinical trials and monitoring for adverse drug reactions. But AI can also help improve pharma manufacturing, distribution, and supply chain management by improving efficiency, safety, quality, and other processes. Here’s how AI can be used to improve…
